Characterization of recombinant Streptococcus mitis-derived human platelet aggregation factor

APMIS

Volumn 120, Issue 1, 2012, Pages 56-71

  Ohkuni, Hisashi ^a   Nagamune, Hideaki ^b   Ozaki, Nana ^b   Tabata, Atsushi ^b   Todome, Yuko ^c   Watanabe, Yukino ^c   Takahashi, Hidemi ^c   Ohkura, Kazuto ^d   Kourai, Hiroki ^b   Ohtsuka, Hiroki ^a   Fischetti, Vincent A ^e   Zabriskie, John B ^e  

^a Health Sciences Research Institute East Japan Company Limited   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d CHIBA INSTITUTE OF SCIENCE   (Japan)

^e ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Human platelet aggregation factor; Kawasaki disease; Pneumolysin; Streptococcus mitis; Suilysin

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; CHOLESTEROL DEPENDENT CYTOLYSIN; CYTOLYSIN; FUCOLECTIN RELATED PROTEIN; LECTINOLYSIN; LYSINE DERIVATIVE; PNEUMOLYSIN; RECOMBINANT PROTEIN; RECOMBINANT STREPTOCOCCUS MITIS DERIVED HUMAN PLATELET AGGREGATION FACTOR; SUILYSIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; ERYTHROCYTE; ESCHERICHIA COLI; HEMOLYSIS; HUMAN; MUCOCUTANEOUS LYMPH NODE SYNDROME; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE HOMOLOGY; STREPTOCOCCUS MITIS; THROMBOCYTE AGGREGATION; TOOTH; TRANSMISSION ELECTRON MICROSCOPY;

ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; BASE SEQUENCE; BLOOD PLATELETS; CELL ADHESION MOLECULES; CHOLESTEROL; CYTOTOXINS; DNA, BACTERIAL; FEMALE; GENES, BACTERIAL; HEMOLYSIN PROTEINS; HUMANS; L-LACTATE DEHYDROGENASE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR SEQUENCE DATA; MUCOCUTANEOUS LYMPH NODE SYNDROME; PHYLOGENY; PLATELET AGGREGATION; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; STREPTOCOCCUS MITIS; STREPTOLYSINS;

EID: 83555177313     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2011.02813.x     Document Type: Article

References (30)

1. Evans AS. Discussion of etiology. In: Shulman S, editor. Kawasaki Disease. New York, NY, USA: Alan R. Liss Inc., 1987: 141-4.
2. Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, et al. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 1988;48:247-51.
3. Matsushita K, Fujimaki W, Kato H, Uchiyama T, Igarashi H, Ohkuni H, et al. Immunopathological activities of extracellular products of Streptococcus mitis, particularly a superantigenic fraction. Infect Immun 1995;63:785-93.
4. Takada H, Kawabata Y, Tamura M, Matsushita K, Igarashi H, Ohkuni H, et al. Cytokine induction by extracellular products of oral viridans group streptococci. Infect Immun 1993;61:5252-60.
5. Yanagawa I. Epidemiology of Kawasaki disease in Japan. In: Shulman S, editor. Kawasaki Disease. New York, NY, USA: Alan R. Liss Inc., 1987: 5-17.
6. Yanagawa I. Epidemiological pictures of Kawasaki disease in Japan. In: Takahashi M, Taubert K, editors. Proceeding of the Fourth International Symposium on Kawasaki Disease. Dallas, TX, USA: Am. Heart Assoc., 1993: 1-9.
7. Ohkuni H, Todome Y, Mizuse M, Ohtani N, Suzuki H, Igarashi H, et al. Biologically active extracellular products of oral viridans streptococci and the aetiology of Kawasaki disease. J Med Microbiol 1993;39:352-62.
8. Kawamura Y, Whiley RA, Shu S-E, Ezaki T, Hardie JM. Genetic approaches to the identification of the mitis group within the genus Streptococcus. Microbiology 1999;145:2605-13.
9. Ohkuni H, Todome Y, Okibayashi F, Watanabe Y, Ohtani N, Ishikawa T, et al. Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65. FEMS Immunol Med Microbiol 1997;17:121-9.
10. Tweten RK. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect Immun 2005;73:6199-209.
11. Alouf JE. Molecular features of the cytolytic pore-forming bacterial protein toxins. Folia Microbiol 2003;48:5-16.
12. O'Connor SP, Cleary PP. In vivo Streptococcus pyogenes C5a peptidase activity; analysis using transposon- and nitrosoguanidine-induced mutants. J Infect Dis 1987;156:495-504.
13. Sambrook J, Fritsh EF, Maniatis T. Analysis of genomic DNA by Southern hybridization in molecular cloning. In: Sambrook J, Fritsh EF, Maniatis T, editors. A Laboratory Manual. New York, NY, USA: Cold Spring Laboratory Press, 1989: 9.31-57.
14. Watanabe Y, Ohkuni H. Human platelet aggregation factor produced by Streptococcus mitis. NCBI Sequence Viewer 2006; v2.0 (Published only in Database).
15. Tomoyasu T, Arsene F, Ogura T, Ogura T, Bukau B. The C terminus of sigma(32) is not essential for degradation by FtsH. J Bacteriol 2001;183:5911-7.
16. Gamer J, Bujard H, Bukau B. Physical interaction between heat shock proteins DnaK, DnaJ, and GrpE and the bacterial heat shock transcription factor sigma 32. Cell 1992;69:833-42.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
18. Ohkuni H, Todome Y, Yoshimura K, Yamamoto T, Suzuki H, Yokomuro K, et al. Detection of nephritis strain-associated streptokinase by monoclonal antibodies. J Med Microbiol 1991;35:60-63.
19. Blake MS, Johnston KH, Russell-Jones GJ, Gotschlich EC. A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal Biochem 1984;136:175-9.
20. Reynolds ES. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 1963;17:208-12.
21. Farrand S, Hotze E, Friese P, Hollingshead SK, Smith DF, Cummings RD, et al. Characterization of a streptococcal cholesterol-dependent cytolysin with a Lewis y and b specific lectin domain. Biochemistry 2008;47:7097-107.
22. Nagamune H, Ohnishi C, Katsuura A, Fushitani K, Whiley RA, Tsuji A, et al. Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess. Infect Immun 1996;64:3093-100.
23. Jefferies J, Nieminen L, Kirkham L-A, Johnston C, Smith A, Mitchell TJ. Identification of a secreted cholesterol-dependent cytolysin (mitilysin) from Streptococcus mitis. J Bacteriol 2007;189:627-32.
24. Gelber SE, Aguilar JL, Lewis KL, Ratner AJ. Functional and phylogenetic characterization of vaginolysin, the human-specific cytolysin from Gardnerella vaginalis. J Bacteriol 2008;190:3896-903.
25. Dubail I, Autret N, Beretti J-L, Kayal S, Berche P, Charbit A. Functional assembly of two membrane-binding domains in listeriolysin O, the cytolysin of Listeria monocytogenes. Microbiology 2001;147:2679-88.
26. Heuck AP, Tweten RK, Johnson AE. Beta-barrel pore-forming toxins: intriguing dimorphic proteins. Biochemistry 2001;40:9065-73.
27. Rossjohn J, Feil SC, McKinstry WJ, Tweten RK, Parker MW. Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell 1997;89:685-92.
28. Havarstein LS, Hakenbeck R, Gaustad P. Natural competence in the genus Streptococcus; evidence that streptococci can change phenotype by interspecies recombinational exchange. J Bacteriol 1997;179:6589-94.
29. Nakamura M, Sekino N, Iwamoto M, Ohno-Iwashita Y. Interaction of theta-toxin (perfringolysin O), a cholesterol-binding cytolysin, with liposomal membranes: change in the aromatic side chains upon binding and insertion. Biochemistry 1995;34:6513-20.
30. Nagamune H, Ohkura K, Sukeno A, Cowan G, Mitchell TJ, Ito W, et al. The human-specific action of inermedilysin, a homology of streptolysin O, is dictated by domain 4 of the protein. Microbiol Immunol 2004;48:677-92.